Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)
NCT05396898
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Posttransplant Diabetes Mellitus
Interventions
DRUG:
LCP-tacrolimus
DRUG:
twice-daily tacrolimus
Sponsor
University Hospital Tuebingen